Authors:
Fujiwara, H
Emi, M
Nagai, H
Ohgaki, K
Imoto, I
Akimoto, M
Ogawa, O
Habuchi, T
Citation: H. Fujiwara et al., Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line, J HUM GENET, 46(7), 2001, pp. 372-377
Authors:
Habuchi, T
Takahashi, T
Kakinuma, H
Wang, LZ
Tsuchiya, N
Satoh, S
Akao, T
Sato, K
Ogawa, O
Knowles, MA
Kato, T
Citation: T. Habuchi et al., Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer, ONCOGENE, 20(4), 2001, pp. 531-537
Authors:
Satoh, S
Tada, H
Tachiki, Y
Tsuchiya, N
Shimoda, N
Akao, T
Sato, K
Habuchi, T
Suzuki, T
Kato, T
Citation: S. Satoh et al., Chrono and clinical pharmacokinetic study of tacrolimus in continuous intravenous administration, INT J UROL, 8(7), 2001, pp. 353-358
Authors:
Kakinuma, H
Habuchi, T
Ito, T
Mishina, M
Sato, K
Satoh, S
Akao, T
Ogawa, O
Kato, T
Citation: H. Kakinuma et al., BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors, CANC GENET, 126(2), 2001, pp. 134-138
Authors:
Takahashi, T
Kakehi, Y
Mitsumori, K
Akao, T
Terachi, T
Kato, T
Ogawa, O
Habuchi, T
Citation: T. Takahashi et al., Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors, J UROL, 165(2), 2001, pp. 672-677
Authors:
Wu, XX
Kakehi, Y
Takahashi, T
Habuchi, T
Ogawa, O
Citation: Xx. Wu et al., Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence, INT J UROL, 7(6), 2000, pp. 210-217
Authors:
Sasaki, R
Habuchi, T
Sato, K
Akao, T
Kakinuma, H
Zhang, LQ
Wang, LZ
Matsuo, S
Sasaki, S
Ogawa, O
Kato, T
Citation: R. Sasaki et al., The clinical utility of measuring total PSA, PSA density, gamma-seminoprotein and gamma-seminoprotein/total PSA in prostate cancer prediction, JPN J CLIN, 30(8), 2000, pp. 337-342
Authors:
Tsuchiya, N
Sato, K
Shimoda, N
Satoh, S
Habuchi, T
Ogawa, O
Kato, T
Citation: N. Tsuchiya et al., An accessory spleen mimicking a nonfunctional adrenal tumor: A potential pitfall in the diagnosis of a left adrenal tumor, UROL INTERN, 65(4), 2000, pp. 226-228
Authors:
Habuchi, T
Zhang, LQ
Suzuki, T
Sasaki, R
Tsuchiya, N
Tachiki, H
Shimoda, N
Satoh, S
Sato, K
Kakehi, Y
Kamoto, T
Ogawa, O
Kato, T
Citation: T. Habuchi et al., Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect, CANCER RES, 60(20), 2000, pp. 5710-5713
Authors:
Habuchi, T
Suzuki, T
Sasaki, R
Wang, LZ
Sato, K
Satoh, S
Akao, T
Tsuchiya, N
Shimoda, N
Wada, Y
Koizumi, A
Chihara, J
Osamu, OA
Kato, T
Citation: T. Habuchi et al., Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population, CANCER RES, 60(2), 2000, pp. 305-308
Authors:
Kato, T
Tsuchiya, N
Sato, K
Ogawa, O
Sasaki, R
Schimoda, N
Satoh, S
Habuchi, T
Citation: T. Kato et al., Elevated vascular endothelial growth factor (VEGF) and normal level of basic fibroblast growth factor (bFGF) in the sera of patients with renal cell carcinoma, AKT UROL, 31, 2000, pp. 15-17
Authors:
Ogawa, O
Suzuki, T
Habuchi, T
Sasaki, R
Tachiki, Y
Akao, T
Tsuchiya, N
Kato, T
Citation: O. Ogawa et al., Association of vitamin D receptor gene polymorphism with protection against prostate cancer and benign prostate hyperplasia, PROSTATE C, 2, 1999, pp. S24-S24
Authors:
Nishiyama, H
Takahashi, T
Kakehi, Y
Habuchi, T
Knowles, MA
Citation: H. Nishiyama et al., Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer, GENE CHROM, 26(2), 1999, pp. 171-175
Authors:
Takahashi, T
Habuchi, T
Kakehi, Y
Mitsumori, K
Akao, T
Terachi, T
Yoshida, O
Citation: T. Takahashi et al., Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract, CANCER RES, 58(24), 1998, pp. 5835-5841